Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
REVENUES        
Government contract revenue $ 131,966 $ 0 $ 263,932 $ 0
OPERATING EXPENSES        
Professional fees 649,460 656,396 1,232,929 1,220,680
Payroll and related expenses 805,608 560,244 1,822,350 997,155
General and administrative 685,702 554,749 1,315,895 964,700
Total operating expenses 2,140,770 1,771,389 4,371,174 3,182,535
OPERATING LOSS (2,008,804) (1,771,389) (4,107,242) (3,182,535)
NET LOSS (2,008,804) (1,771,389) (4,107,242) (3,182,535)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (825) (825) (1,960) (1,688)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,007,979) $ (1,770,564) $ (4,105,282) $ (3,180,847)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.13) $ (0.15) $ (0.29) $ (0.29)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED 15,386,486 12,070,592 14,114,639 10,845,049